CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Review CIRB
Study Status
Study Number Sort descending Lead Group Study Title CIRB Study Status
EAQ171CD ECOG-ACRIN Implementing a Virtual Tobacco Treatment in Community Oncology Practices: “Smoke Free Support Study 2.0” Cancer Prevention and Control CIRB Available to Open
EAQ172 ECOG-ACRIN Optimizing Immunosuppression for Steroid- Refractory Anti-PD-1/PD-L1 Pneumonitis Cancer Prevention and Control CIRB Available to Open
EAQ191 ECOG-ACRIN Cancer Therapy Risk-Reduction with Intensive Systolic BP Management (CARISMA) – a Phase II Study Cancer Prevention and Control CIRB Available to Open
EAQ201 ECOG-ACRIN COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation Cancer Prevention and Control CIRB Completed
EAQ202 ECOG-ACRIN Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials Cancer Prevention and Control CIRB Available to Open
EAQ211 ECOG-ACRIN Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin Lymphoma Cancer Prevention and Control CIRB Available to Open
EAQ221CD ECOG-ACRIN Improving Medication Adherence in Metastatic Breast Cancer using a CONnected CUstomized Treatment Platform (CONCURxP) Cancer Prevention and Control CIRB Available to Open
EAQ222CD ECOG-ACRIN Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients Cancer Prevention and Control CIRB Available to Open
EAY131 ECOG-ACRIN Molecular Analysis for Therapy Choice (MATCH) Adult CIRB - Early Phase Emphasis Available to Open
EAY191 ECOG-ACRIN Molecular Analysis for Combination Therapy Choice (ComboMATCH) Adult CIRB - Early Phase Emphasis Available to Open